Bruce Clark

Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin

Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management

The FGF family: biology, pathophysiology and therapy

Treatment of IgM antibody associated polyneuropathies using rituximab

Antibody therapy of cancer

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Tissue‐specific responses to aberrant FGF signaling in complex head phenotypes

Brain malformation in syndromic craniosynostoses, a primary disorder of white matter: a review

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

The Fibroblast Growth Factor signaling pathway

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Monoclonal Antibodies for Cancer Therapy

How I treat Waldenström macroglobulinemia

Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

Central Nervous System Imaging in Crouzonʼs Syndrome

CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom’s Macroglobulinemia